The QualityStocks Daily Stock List
- Western Uranium & Vanadium Corp. (WSTRF)
- DATATRAK International, Inc. (DTRK)
- Rokk3r, Inc. (ROKK)
- Bitfarms Ltd. (BLLCF)
- CLIC Technology, Inc. (CLCI)
- Rubicon Organics, Inc. (ROMJF)
- STWC Holdings, Inc. (STWC)
- CreditRiskMonitor.com, Inc. (CRMZ)
- Wize Pharma, Inc. (WIZP)
- BioCardia, Inc. (BCDA)
- Anvia Holdings Corporation (ANVV)
- RespireRx Pharmaceuticals, Inc. (RSPI)
- Rainforest Resources, Inc. (RRIF)
- AEON Global Health Corp. (AGHC)
Western Uranium & Vanadium Corp. (WSTRF)
Streetwise Reports, Zacks, Vanadium Price, Stockhouse, Energy and Capital, Proactive Investors, YCharts, Barchart, Investor Intel, Stockwatch, Morningstar, Market Screener, Dividend Investor, Trading View, Marketbeat, Junior Mining Network, GlobeNewswire, Business Insider, The Street, Nasdaq, Canadian Insider, Last10k, and MarketWatch reported beforehand on Western Uranium & Vanadium Corp. (WSTRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Western Uranium & Vanadium Corp. is a uranium and vanadium conventional mining enterprise. The Company focuses on low cost near-term production of uranium and vanadium in the western U.S., as well as the development and application of ablation mining technology. Ablation Mining Technology (AMT) is a proprietary process. It improves efficiency and lessens costs for sandstone hosted deposits. OTCQX-listed, Western Uranium & Vanadium has offices in Toronto, Ontario and Nucla, Colorado.
The Company is among the largest U.S. Uranium and Vanadium in-situ resource holders. It has a total uranium resource of 70,000,000 lbs. +/- and a total vanadium resource of 35,000,000 lbs. +/- grading between 1.4-2.2 percent. Its near-term production strategy includes concentrating on previously producing mines for low CAPEX (capital expenditure), existing infrastructure & permitting.
Western Uranium & Vanadium’s strategy also includes defining and developing a high-grade vanadium resource at the Sunday Mine Complex (SMC). Furthermore, the Company’s strategy is to deliver SMC ore samples to numerous potential customers and joint venture (JV) partners, and baseload SMC production with a vanadium ore concentrate agreement. Additionally, its strategy is to pursue vanadium development at the Sage Mine Project. The Company will also work to pursue uranium contracts and development at prices above present price levels.
Funding for the Sunday Mine Complex (the SMC) Vanadium Project was completed in April of this year. Project planning has been ongoing. The SMC comprises five individual permitted and developed mines in Western Colorado. Western Uranium & Vanadium has now assembled the personnel and resources to open the Sunday Mine Complex. The Company will begin the Project at two mines - the Sunday Mine and the St. Jude Mine.
After mine opening, vanadium ore samples will be delivered to vanadium processors and users worldwide. The emphasis of the present Project is to define the high-grade vanadium deposit. Underground drilling, in addition to bulk sampling, will be used to ascertain the vanadium resource. Historically, the SMC yielded a 6-to-1 vanadium-to-uranium ratio.
Dr. Kaiwen Wu has been added to the Western Uranium & Vanadium team as Chief Geologist to oversee the Project. Dr. Wu is a preeminent expert on conventional sandstone hosted vanadium/uranium deposits. He has wide-ranging experience in the Colorado/Utah Mineral Belt.
Western Uranium & Vanadium Corp. (WSTRF), closed Monday's trading session at $1.04, up 4.00%, on 14,095 volume with 25 trades. The average volume for the last 3 months is 14,095 and the stock's 52-week low/high is $0.67/$2.70.
DATATRAK International, Inc. (DTRK)
Zacks, Investor Village, OTC Markets, stock2own, Infront Analytics, Wallmine, Investors Hangout, Whale Wisdom, Capital Cube, Stockwatch, and Marketbeat reported earlier on DATATRAK International, Inc. (DTRK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A technology and services company, DATATRAK International, Inc. provides unified eClinical solutions and related services for the clinical trials industry. The Company is a global Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the life sciences industry. Established in 1991, DATATRAK International lists on the OTC Markets. The Company has its corporate office in Mayfield Heights, Ohio.
The Datatrak Enterprise Cloud supports Pre-clinical and Phase I - Phase IV drug and device studies in manifold languages worldwide. The Datatrak Enterprise Cloud includes many products. These include Clinical Trial Management System (CTMS), Trial Design, Electronic Data Capture (EDC), Medical Coding, Risk Based Monitoring, ECG Data Capture, Image Data Capture, Endpoint Adjudication, Randomization, Clinical Supply Inventory, eConsent, ePRO and Business Analytics.
DATATRAK delivers a complete portfolio of software products. The design of these to hasten the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities more efficiently than loosely integrated technologies. The Company’s vision is to continue to build and own a multilingual and multi-tenant enterprise platform with unified access to clinical applications, database and workflows.
The Company’s dedication is to empowering workgroup teams with role-based access to version-controlled file management, calendar events, tasks and contacts, all built within their eClinical applications. These include EDC, CTMS, reporting, data analytics, as well as business intelligence.
Last month, DATATRAK International announced its operating results for Q1 of 2019. The Company realized its fourth consecutive quarter of profitability. It saw an increase in Revenue during the three months ended March 31, 2019. Revenue for Q1 2019 was $1,922,000 versus $1,754,000 for Q1 2018.
DATATRAK had Income from Operations for the three months ended March 31, 2019, of $165,000 versus an Operating Loss of ($112,000) for the three months ended March 31, 2018. Its Net Income for the three months ended March 31, 2019 was $166,000 versus a Net Loss of ($110,000) for the three months ended March 31, 2018.
DATATRAK International, Inc. (DTRK), closed Monday's trading session at $6.40, up 18.52%, on 3,675 volume with 13 trades. The average volume for the last 3 months is 268 and the stock's 52-week low/high is $2.31/$8.00.
Rokk3r, Inc. (ROKK)
Street Insider, OTC Markets, Stockwatch, Stockhouse, Biz Journals, MarketWatch, PR Newswire, GlobeNewswire, Simply Wall St, Lat10k, and Stockopedia reported earlier on Rokk3r, Inc. (ROKK), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Rokk3r, Inc. provides consulting services and related value generating strategies by way of a technology platform. The Company is an international idea-to-exit company builder and consulting services company. The design of its services are to take advantage of exponential technologies to quickly accelerate and shape industries. The Company previously went by the name Eight Dragons Company. It changed its corporate name to Rokk3r, Inc. in March of 2018. Rokk3r is based in Miami, Florida.
The Company provides a set of services that is a hybrid network of human and machine intelligence systems, seeking to enable early stage start-up technology companies and existing businesses to develop new products and businesses in a frictionless, accelerated and complete manner. These exponential technologies include artificial intelligence (AI), augmented and virtual reality (AR, VR), blockchain (decentralized ledger technologies), data science, digital biology and biotech, machine learning, nanotech, robotics, and sensors.
Rokk3r’s ecosystem approach lessens friction and streamlines execution through leveraging talent, shared services, experience, and also networks. The Company offers business diagnosis to strategy design, execution and funding. Rokk3r has operations in three continents. It has built and funded more than 40 companies. More than 160 ideas have been exponentiated. The Company’s expertise is in Blockchain, AI, IoT (Internet of Things), and Big Data for the FinTech, Digital Marketing, PropTech, and Industry Services sectors.
Rokk3r has acquired Bullfrog Ventures. Bullfrog was founded in 2016 to speed up the transition of insurance solutions to be more predictive and preventive, decreasing material damages and improving people's lives. Since its inception, Bullfrog Ventures has played a pivotal role in the development of manifold enterprise-level firms in North and South America. Its Insurtech Portal, in partnership with Chubb Latin America, includes greater than 80 Insurtechs. It is complemented by its global relationships, with such ecosystems as the Luxembourg House of Fintech (LHoFT). Bullfrog's Insurtech platform includes 16 curated insurtechs from all over the world.
Last week, Rokk3r announced that it appointed Mr. Gonzalo Nuñez as Country Manager, Mexico, boosting its presence in the region. In this new role, Mr. Nuñez will lead business development activities and Rokk3r’s Mexico operations, with an emphasis on driving business transformation through building exponential companies led by Mexican entrepreneurs and corporate entities. Mr. Nuñez has been responsible for IT (Information Technology) strategy practices, business architecture, risks and regulation, having served as a Partner in three of the primary Business & Technology Consulting firms in Mexico, Accenture, Price Waterhouse Coopers, and Ernst & Young.
Rokk3r, Inc. (ROKK), closed Monday's trading session at $1.00, up 33.33%, on 180 volume with 3 trades. The average volume for the last 3 months is 2,458 and the stock's 52-week low/high is $0.4975/$4.00.
Bitfarms Ltd. (BLLCF)
OTC Markets, Street Insider, Finance Magnates, 4-Traders, Dividend Investor, Blockchain Stocks, Bitcoin News, TradingView, Stockhouse, and Stockwatch reported earlier on Bitfarms Ltd. (BLLCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Bitfarms Ltd. is one of the largest blockchain infrastructure companies in the world via its ownership of Backbone Hosting Solutions, Inc., operating under the name “Bitfarms”. Bitfarms Ltd. was previously Bitfarms Technologies Ltd. and Blockchain Mining Ltd. By way of its ownership of Bitfarms, the Company owns and operates blockchain farms that power the worldwide decentralized financial economy. OTCQX-listed, Bitfarms has its corporate headquarters in Brossard, Quebec.
The Company is building infrastructure for the future through developing and hosting the ecosystem growing around blockchain-based technologies. Bitfarms operates four blockchain farms in the Province of Quebec, with an installed capacity of 36MW and roughly 220 Ph/s of installed hash power. These are powered by clean and competitively priced hydroelectricity.
The Company provides computing power to cryptocurrency networks such as Bitcoin, earning fees from each network for securing and processing transactions. Bitfarms’ 100 percent vertically integrated operation handles everything from design, construction and operations - all mastered in-house by its employees and contractors.
Bitfarms’ competitive advantages include 100 percent owned and operated farms and clean and renewable energy. The Company has first-rate reciprocal relationships with top chip and hardware manufacturers. Bitfarms has a team of 24 electricians in-house. Therefore, it can easily manage 24/7 shifts and expedited facility buildouts. The Company regularly sells mined coins and redeploys the proceeds into continuing growth following what it says is its prudent capital allocation strategy. Moreover, Bitfarms has its on-site repair lab and training center.
In May, Bitfarms announced the Company is pleased with the Energy Board of Quebec’s decision to not apply an electricity price increase to the blockchain industry within the Province. In a decision decreed on April 29, 2019, the Energy Board rejected Hydro Quebec’s targeted rate increase for cryptocurrency miners. It also rejected the proposed price bidding mechanism for the allocation of new energy blocks.
The Energy Board decided to allocate an aggregate additional supply of 300 megawatts of electricity to blockchain customers, in addition to the 368 MW earlier granted to existing customers such as Bitfarms. Bitfarms was an active participant in the hearings held during the summer and fall of 2018 at the Energy Board.
Bitfarms Ltd. (BLLCF), closed Monday's trading session at $3.00, up 50.00%, on 1,693 volume with 4 trades. The average volume for the last 3 months is 6,392 and the stock's 52-week low/high is $0.00009/$3.00.
CLIC Technology, Inc. (CLCI)
Investing News, Stockhouse, Street Insider, Stockwatch, Stock of the Week, Make Penny Stocks Great Again, OTC Market Research, GuruFocus, PennyStocks.News, BlockChainWire, InvestorsHub, and Simply Wall St reported previously on CLIC Technology, Inc. (CLCI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
A "Financial Technology" company, CLIC Technology, Inc. is the developer and marketer of new, pioneering blockchain products and services. It has created an innovative "crypto-payment gateway system." This system enables consumers to use cryptocurrency to make routine purchases online. The system enables merchants to accept crypto payments and receive immediate settlements in traditional fiat currencies.
CLIC Technology has its head office in Aventura, Florida. The Company lists on the OTC Markets. Market introduction of the new crypto-payment gateway system and related services is planned to take place in a phased rollout in the United States and other major markets in the coming months.
CLIC Technology is lending its services to the developing cannabis and CBD (cannabidiol) industries. The Company is joining forces with Chicago’s LeafyQuick CBD Delivery Service. LeafyQuick has opted to register for CLIC’s ClicPay online payment gateway pilot program, a cutting-edge cryptocurrency platform for merchants that will accept blockchain payments and convert them into local currency securely, all within 24 hours.
This program is a step towards the future for companies such as LeafyQuick. It permits them to sidestep burdensome regulations imposed by payment processors over an industry that experts predict will soon be worth upwards of $20 billion. The ClicPay Merchant Gateway will offer LeafyQuick and others like them a fast setup with simple integration. This is an option that gives the whole CBD industry the capability to start accepting cryptocurrency payments instantly.
CLIC Technology Chief Executive Officer, Roman Bond, said, “We are extremely excited to be working with LeafyQuick, and to be able to help move the CBD industry forward. Turning cryptocurrency into everyday fiat is going to be a game-changer for many in the industry.”
CLIC Technology, in collaboration with blockchain infrastructure provider and B2B platform Opporty, is ready to launch a progressive browser extension that will revolutionize the e-commerce industry. It will allow consumers to make everyday purchases on Amazon using the open source, public, blockchain-based distributed computing platform Ethereum.
Powered by Plasma Cash design pattern for off-chain processing of an on-chain assets provided by Opporty, the new extension will bring a modern day cryptocurrency economy one step closer to becoming a reality. The two companies plan to create payment platforms processing Ethereum, as well as any tokens based on ERC-20, ERC-721, and other Ethereum compatible standards. This will open up a host of possibilities for consumers to use digital currency in the e-commerce marketplace.
CLIC Technology, Inc. (CLCI), closed Monday's trading session at $2.76, up 126.23%, on 1,086,710 volume with 1,750 trades. The average volume for the last 3 months is 87,382 and the stock's 52-week low/high is $0.0106/$10.00.
Rubicon Organics, Inc. (ROMJF)
Pot Stock News, Investors News, Financial Buzz, BioSpace, Green Market Report, OTC Markets, technical420, CannabisMarketCap, TheCannalysts, Stockhouse, Stockwatch, Investorx, and Trading View reported previously on Rubicon Organics, Inc. (ROMJF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Rubicon Organics, Inc. is a Licensed Producer (LP) centered on building super-premium organic cannabis brands (Organic certification pending from FVOPA) with operations in Canada, Washington and California. The Company’s flagship Canadian facility is a 125,000 sq. ft. state-of-the-art hybrid greenhouse with industry-leading LED lighting. It is located on a 20-acre property in Delta, British Columbia. Rubicon Organics has its corporate office in Vancouver, British Columbia.
Rubicon’s Washington facility is a newly constructed 40,000 square-foot high-tech hybrid greenhouse. The Company has started production in both facilities with a combined Phase I capacity of 15,500 kg per year. This includes 4,500 kg leased to a Washington State licensed operator applying Rubicon Organics' proprietary organic cultivation methods. In addition, Rubicon owns two award-winning U.S. cannabis brands. One is 1964 Supply Co.™ in California. The other is Doctor & Crook Co.™ in Washington.
Rubicon Organics has one of the largest licensed footprints for organic cannabis in Canada. The Company’s team wrote the first organic regulatory standard for certified organic cannabis production. Rubicon has custom designed facilities in the best growing climates, a European distribution partnership secured, and multi-jurisdictional operations and sales. It also has distinguished brands in influential markets.
The Company’s plants are grown in proprietary soil made with certified organic ingredients. Each stage of the growing process is carried out by hand - from planting to packaging. Everything that goes into its plants comes from the ground and the ocean. Rubicon’s process replicates outdoor growing techniques.
At the end of April 2019, Rubicon Organics announced the successful completion of the first commercial scale, organic harvest at its newly constructed hybrid facility in Ferndale, Washington. The Washington Facility is a high-tech, venlo-style greenhouse. It is located on 16.6 acres of industrial land in Ferndale, Washington. Rubicon has leased the Washington Facility to an I-502 Tier 3-licensed tenant in compliance with the Washington State Liquor and Cannabis Board. Because of the successful harvest, Rubicon has now initiated brand licensing discussions for the launch of the 1964 Supply Co.™ brand in Washington State.
Last week, Rubicon Organics announced that it has partnered with Cookies, a top lifestyle and cannabis brand in California. This partnership is to exclusively license the Cookies brand in Washington State. Via this partnership, Cookies cannabis strains will be grown at Rubicon’s Washington greenhouse that is leased to an I-502 Tier 3-licensed Washington operator that applies Rubicon Organics' proprietary cultivation methods to produce super-premium cannabis.
Jesse McConnell, Founder and Chief Executive Officer of Rubicon Organics, said, "The fact that Cookies – one of the top brands in California – has chosen Rubicon Organics to license its highly coveted cannabis strains is a testament to the strong commercial appeal of Rubicon's unique cultivation methods. Our proprietary cultivation methodologies will enable the fullest expression of Cookies' cannabis genetics and we are looking forward to working alongside the Cookies team to spread their iconic brand across Washington State."
Rubicon Organics, Inc. (ROMJF), closed Monday's trading session at $2.467, up 7.261%, on 3,658 volume with 26 trades. The average volume for the last 3 months is 3,753 and the stock's 52-week low/high is $1.298/$2.50.
STWC Holdings, Inc. (STWC)
CannabisFN, StocksBeat, All Stocks Today, Street Insider, PotNetwork, Cannabis Dispensary, OTC Markets, Cannabis Business Times, Invest Tribune, Stock Target Advisor, Real Investment Advice, OTC.Watch, InvestorsHub, Simply Wall St, Stockhouse, 4-Traders, and Seeking Alpha reported earlier on STWC Holdings, Inc. (STWC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
STWC Holdings, Inc. is a foremost cannabis consultant and industry pioneer listed on the OTC Markets Group’s OTCQB. It offers a wide-ranging ecosystem of entities and services, which support the expanding cannabis industry. Established in 2012, the Company was previously known as Strainwise, Inc. It changed its name to STWC Holdings, Inc. in June of 2016. STWC has its corporate office in Lakewood, Colorado. The Company offers capital, strategic partnership, and seed-to-sale consulting. It also offers design, marketing and advertising services. STWC provides its partners access to its complete suite of assets. It develops made-to-order solutions to address the range of challenges that cannabis entrepreneurs and businesses face.
SquareOne™ is the Company’s 3-phase consulting platform. It assists cannabis entrepreneurs in launching their new businesses successfully - with measurable results. With SquareOne™, STWC is able to deliver concise consulting services to cannabis entrepreneurs. The SquareOne™ consulting platform guides clients in understanding the financial dimensions and market conditions in their respective jurisdictions.
This past April, STWC Holdings announced that it executed a joint venture (JV) for the development of an innovative software package customized for the cannabis industry. The agreement with Dana Ress of Denver’s RedPoint Solutions will result in a software solution named Supergrower, targeted for July, which will address the complexities of conducting business in the arena of legal marijuana, with functionality across all four cannabis verticals: cultivation, manufacturing, distribution and retail.
STWC Holdings Chief Executive Officer, Erin Phillips, said, “After working with hundreds of operators in the cannabis industry, we realized that most operators are looking for powerful tools to manage their day-to-day operations and plan for the future. As cannabis businesses continue to evolve and mature, this issue will become increasingly insurmountable. Supergrower will provide the business analytics necessary for an operator to thrive in today’s cannabis industry.”
Under the JV, STWC Holdings and Ress will work together to develop an efficient and scalable software platform. It will be the first complete management system for the cannabis industry. The design of the Supergrower platform, an SaaS product, is to operate across all standalone software, aggregating data, performing analytics, and providing valuable insights to customers through customizable reports and dashboards.
STWC Holdings, Inc. (STWC), closed Monday's trading session at $1.00, even for the day, on 800 volume with 7 trades. The average volume for the last 3 months is 742 and the stock's 52-week low/high is $0.20/$2.90.
CreditRiskMonitor.com, Inc. (CRMZ)
MarketWatch, Simply Wall St, Street Insider, Stockhouse, GlobeNewswire, InvestorsHub, Morningstar, YCharts, OTC Markets, Marketbeat, Seeking Alpha, GuruFocus, Last10k, Zacks, Barchart, and Marketwired reported on CreditRiskMonitor.com, Inc. (CRMZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Established in 1977, CreditRiskMonitor.com, Inc. is a financial risk analysis and news service for credit, supply chain and financial professionals. Fundamentally, the Company is a web-based publisher of financial information. Its financial information helps corporate credit and procurement professionals stay ahead of business financial risk quickly, accurately, as well as cost effectively. CreditRiskMonitor.com lists on the OTC Markets’ OTCQX. The company has its corporate office in Valley Cottage, New York.
CreditRiskMonitor.com provides timely news alerts and reports. These feature detailed analyses of financial statements. In addition, it provides ratio analysis and trend reports, peer analyses, bond agency ratings, and crowdsourcing of risk professionals. Furthermore, it provides its proprietary FRISK® and PAYCE® scores.
The Company’s 96 percent accurate FRISK® score is formulated to assess bankruptcy risk in public companies within a 12-month window. The FRISK® score incorporates several critical risk indicators. These include crowdsourced click patterns of credit professionals as well as other subscribers.
CreditRiskMonitor.com’s PAYCE® Score is a predictive score for private company bankruptcy risk using deep neural network technology. This is a type of artificial intelligence (AI). The PAYCE® score provides a highly accurate measure of financial stress when no financial statements are available for private companies. The PAYCE® Score uses payment and U.S. federal tax lien data from CreditRiskMonitor’s wide-ranging database.
Recently, CreditRiskMonitor.com reported that Revenues for the year ended December 31, 2018 rose to $13.89 million. This is up 4 percent versus 2017. It reported a pre-tax Loss of $192,200 for 2018 versus $230,700 in the year previous.
Net Loss for 2018 was $179,300 versus Net Income of $12,100 in the year prior, as it recorded a benefit from income taxes of close to $221,000 in 2017 related to the lowering corporate income tax rates from a maximum of 35 percent to a flat 21 percent rate effective January 1, 2018. Cash and Cash Equivalents at the end of 2018 decreased to $8.07 million from the 2017 year-end balance of $8.74 million.
CreditRiskMonitor.com, Inc. (CRMZ), closed Monday's trading session at $1.59, up 22.31%, on 26,214 volume with 8 trades. The average volume for the last 3 months is 919 and the stock's 52-week low/high is $1.25/$2.45.
Wize Pharma, Inc. (WIZP)
Dividend Investor, Stockwatch, Capital Cube, Cardinal Weekly, Investors Hangout, Insider Mole, Stockopedia, Penny Stock Hub, Stockhouse, InvestorsHub, Wallmine, OTC Markets, Barchart, MarketWatch, and 4-Traders reported earlier on Wize Pharma, Inc. (WIZP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Wize Pharma, Inc. focuses on the treatment of ophthalmic disorders. This includes dry eye syndrome (DES). The OTCQB-listed Company previously went by the name Star Night Technologies Ltd. It changed its corporate name to Wize Pharma, Inc. in July of 2015. A clinical-stage biopharmaceutical enterprise, the Company is headquartered in Hod Hasharon, Israel.
Wize Pharma has in-licensed certain rights to purchase, market, sell, and distribute a formula named LO2A. This is a drug developed for the treatment of DES, and other ophthalmological illnesses, including conjunctivochalasis (CCH) and Sjögren's Syndrome. Currently, LO2A is registered and marketed by its inventor in Germany and Switzerland for the treatment of DES, in Hungary for the treatment of DES and CCH, and in the Netherlands for the treatment of DES and Sjögren's Syndrome.
Wize Pharma is now conducting a Phase II trial of LO2A for patients with CCH and a Phase IV study for LO2A for DES in patients with Sjögren's. The Company announced in March of last year that it enrolled the initial patient in its Phase IV clinical trial in Israel for LO2A in the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren's syndrome. This randomized, double-masked study is evaluating LO2A versus Alcon's Systane® Ultra UD, an over-the-counter (OTC) lubricant eye drop product used to relieve dry and irritated eyes.
The design of the study (in addition to meeting marketing approval requirements in Israel) is to support Wize Pharma’s clinical approval pathway for LO2A for the treatment of DES in patients with Sjögren's in other markets including the U.S., China, and Ukraine. LO2A is already approved in Israel for the treatment of DES.
Recently, Wize Pharma announced top line results from its Phase II clinical trial in Israel of LO2A for the symptomatic treatment of dry eye syndrome (DES) in patients with moderate to severe conjunctivochalasis (CCh). Wize Pharma's Chairman, Noam Danenberg, stated, "We are very pleased with these top line results and we look forward to analyzing the full results. We believe the full results from this study, will support our clinical development path and provide firm basis for presentation and discussions with the FDA for the approval pathway of LO2A in the U.S. and additional countries."
Wize Pharma also recently announced that it signed an agreement with Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) to form a joint venture (JV) company for researching, developing and administering cannabinoid formulations to treat ophthalmic conditions. Cannabics Pharmaceuticals is a global leader in personalized cannabinoid medicine centered on cancer and its side effects.
This agreement will become effective subject to receipt of an expert opinion, within 30 days from the date of signing, describing the regulatory pathway for eye drops containing cannabinoids. Upon effectiveness, Wize Pharma shall issue 900,000 shares of its common stock to Cannabics Pharmaceuticals. Cannabics shall issue 2,263,944 shares of its common stock to Wize. This agreement will expire if the parties have not approved a business plan by June 30, 2019.
Wize Pharma, Inc. (WIZP), closed Monday's trading session at $0.57, up 16.33%, on 62,350 volume with 17 trades. The average volume for the last 3 months is 43,155 and the stock's 52-week low/high is $0.10/$6.10.
BioCardia, Inc. (BCDA)
Penny Stock Hub, Journal Transcript, Wallmine, TradingView, Insider Financial, 4-Traders, Investing Note, Penny Stock Tweets, Stockwatch, Stockopedia, Simply Wall St, Marketbeat, and MarketWatch reported previously on BioCardia, Inc. (BCDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BioCardia, Inc. is a leader in the development of complete solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company and OTCQB-listed, BioCardia is headquartered in San Carlos, California.
BioCardia’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products. These are partnered to enable other promising biotherapeutic programs. Furthermore, the Helix transendocardial delivery system is being used by a number of clinical partners in biotherapeutic clinical trials.
The Helix transendocardial delivery system is the leading percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene-based therapies to treat heart failure, myocardial infarction, ischemia, as well as cardiac conduction disorders.
The Company’s CardiALLO utilizes younger universal donor mesenchymal stem cells. BioCardia states that CardiALLO may be suitable for patients who are not optimal candidates for the CardiAMP therapy. CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, using a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.
This past November, BioCardia announced positive 12 month data for the roll-in cohort of its pivotal CardiAMP™ Heart Failure Trial studying the investigational CardiAMP Cell Therapy System in adult patients experiencing heart failure after a heart attack. The results were presented on November 12, 2018, by Peter Johnston, MD, of Johns Hopkins Medical Center at the American Heart Association Scientific Sessions 2018.
The expectation is that the continuing multi-center, double-blinded, randomized (3:2), sham-controlled pivotal CardiAMP Heart Failure Trial will enroll 260 patients at up to 40 centers nationwide. The trial’s primary efficacy endpoint is Six Minute Walk distance at 12 months’ post-treatment, a measure of a patient’s exercise capacity, and incorporates the influence of MACE and other clinically meaningful events.
Recently, BioCardia announced its 510(k) submission for U.S. Food and Drug Administration (FDA) clearance of the AVANCE™ steerable introducer, designed for introducing different cardiovascular catheters into the heart. This includes through the left side of the heart via the interatrial septum.
The AVANCE steerable introducer takes advantage of new technology developed for BioCardia’s Morph family of steerable introducers. It applies it for transseptal procedures. The design of the bidirectional AVANCE is to be virtually whipless around curves, because of its helically arranged pull-wires, and provides excellent torsional stiffness. In addition, AVANCE offers a rotating hemostasis port. The intention of these features is to allow more predictability, stability and control during procedures.
BioCardia, Inc. (BCDA), closed Monday's trading session at $1.24, up 22.17%, on 4,250 volume. The average volume for the last 3 months is 482 and the stock's 52-week low/high is $1.20/$32.22.
Anvia Holdings Corporation (ANVV)
High Rising Stocks, Jet Life Penny Stocks, Stockopedia, Barchart, Stockhouse, Simply Wall St, Wallmine, Investors Hangout, Street Insider, Stock Orange, OTC Markets, 4-Traders, GuruFocus, Stockwatch, Penny Stock Hub, Morningstar, and TradingView reported earlier on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Anvia Holdings Corporation is an international technology company that creates comprehensive, turnkey software and consulting solutions for small to medium-sized businesses. The Company is also the world’s complete eco-system for tradesmen in the construction industry. Its businesses serve the complete lifecycle of tradesmen or handymen in the construction industry. Anvia works to build competent tradesmen for the construction industry and make them accessible to the market. The Company has its corporate office in Glendale, California.
Anvia is the first integrated platform for blue-collar workers in the construction industry to provide qualification, licensing, continuous education, placement services, entrepreneurship opportunities, and cash-back or loyalty programs in Australia and globally. The Company has its Anvia College. This College offers quality and world-class education services and products to its aspiring tradesmen and construction workers in a blended learning environment. Anvia College provides essential qualification courses related to the construction environment.
In addition, Anvia offers its Anvia Loyalty. This is a free loyalty program by the Company designed for existing qualified and aspiring tradesmen. Anvia Loyalty is a single platform. It connects the Company’s members to all Anvia products and services.
The Company also has its Anvia Recruiters. Anvia Recruiters provides employment services to graduates of Anvia College and Anvia members around the world. Furthermore, the Company has its Anvia Market. Anvia market is an online store for tradesmen or handymen involved in the construction industry to buy safety wear and tools.
In May 2018, Anvia Holdings announced that it fully acquired Anvia (Australia) Pty Ltd, previously known as Kasa Corporation (Australia) Pty Ltd. Anvia (Australia) Pty Ltd is a fully-owned subsidiary of Anvia Holdings. Anvia Australia commercializes Anvia’s intellectual property (IP) assets. These assets include Anvia Learning, Anvia Market, Anvia Recruiters and Anvia Loyalty in the Australian Market.
At the end of December 2018, Anvia Holdings announced that it signed a definitive agreement to acquire all of the issued and outstanding shares of Workstar Technologies Pty Ltd. This is an Australian corporate training and development institution, trading under the brand Workstar. With this agreement, Anvia Holdings, via its fully owned subsidiary Anvia (Australia) Pty Ltd, will acquire 100 percent of Workstar Technologies Pty Ltd outstanding shares for USD 216,000 (AUD 300,000). Workstar offers tailored digital content and corporate learning to major Australian and international companies.
Recently, Anvia Holdings announced that it signed a definitive agreement to acquire all of the issued and outstanding shares of All Crescent Sdn Bhd. This is a Malaysian company with technology assets including learning management systems, digital content and exclusive licenses with government funding for semiconductor industry technical training.
Anvia Holdings Chief Executive Officer, Ali Kasa, said, “having All Crescent and its subsidiaries as part of our group helps increase our customer base, consolidate our technology assets and lower our operating cost.”
Anvia Holdings Corporation (ANVV), closed Monday's trading session at $1.385, up 27.06%, on 33,731 volume with 00 trades. The average volume for the last 3 months is 000,000 and the stock's 52-week low/high is $0.509/$6.00.
RespireRx Pharmaceuticals, Inc. (RSPI)
NetworkNewsWire, Penny Stock Tweets, Infront Analytics, Stockflare, Barchart, InvestorsHub, Stockopedia, Penny Stock Hub, Wallet Investor, Simply Wall St, Marketbeat, YCharts, Street Insider, Marketwired, Stockhouse, Daily Marijuana Observer, last10k, Investors Hangout, GuruFocus, MarketWatch, Stockwatch, 4-Traders, and Real Investment Advice reported earlier on RespireRx Pharmaceuticals, Inc. (RSPI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
RespireRx Pharmaceuticals, Inc. is a leader in the development of medicines for respiratory disorders and CNS indications, with a concentration on obstructive sleep apnea, attention deficit hyperactivity disorder (ADHD), spinal cord injury, other neurological conditions and drug-induced respiratory depression. RespireRx Pharmaceuticals has its corporate office in Glen Rock, New Jersey. The Company lists on the OTC Markets Group’s OTCQB.
RespireRx has filed over 400 patents in the U.S. and offshore that claim composition of matter, use, formulation, dosage, as well as mechanism of action. Use claims include treating sleep apnea and preventing or rescuing drug-induced respiratory depression, and also for improving memory and cognition, treating schizophrenia and other central nervous system (CNS) indications.
The Company’s pharmaceutical candidates in development are derived from two platforms. One platform is the class of compounds called cannabinoids. This includes, in particular, Dronabinol. Dronabinol (D9-THC, D9-tetrahydrocannabinol) is an oral capsule drug product. Dronabinol (D9-THC) is a generic, orally active cannabinoid. It is undergoing testing for clinical efficacy in patients with obstructive sleep apnea (OSA).
RespireRx Pharmaceuticals (under a license agreement with the University of Illinois) has rights to patents claiming the use of cannabinoids for the treatment of sleep-related breathing disorders. Two Phase 2 clinical trials have been completed. Both have demonstrated substantial reductions in sleep apnea produced by dronabinol.
Dronabinol is Food and Drug Administration (FDA) approved for the treatment of anorexia in AIDS patients and nausea and vomiting in cancer patients undergoing chemotherapy (Marinol®). It is a Schedule III drug available by prescription, with a low risk of addiction.
The other platform of medicines undergoing development by RespireRx is a class of proprietary compounds called ampakines. These act to enhance the actions of the excitatory neurotransmitter glutamate at AMPA glutamate receptor sites in the brain. Several ampakines, in oral and injectable form, are undergoing development by RespireRx for the treatment of an assortment of breathing disorders.
Recently, RespireRx Pharmaceuticals announcd the promotion of Mr. James Sapirstein to Executive Vice Chairman of the Board of Directors effective December 28, 2018. Mr. Sapirstein has served as a member of the Board of Directors since 2014. He expands his role within RespireRx Pharmaceuticals to assist with business development and fundraising activities to advance the development of the Company’s pipeline of neuromodulators with an emphasis on sleep apnea and neurologic and psychiatric disorders.
Mr. Sapirstein is a highly-regarded pharmaceutical industry executive. He has more than 35 years of success in building companies and leading the commercial launch of almost two dozen prescription drugs in the fields of CNS, infectious disease, and cancer. Mr. Sapirstein has worked at major pharmaceutical companies, Bristol-Myers Squibb, Hoffmann-LaRoche and Eli Lilly. He has also led commercial teams for biotechnology companies including Gilead Sciences and Serono Laboratories.
RespireRx Pharmaceuticals, Inc. (RSPI), closed Monday's trading session at $0.675, up 35.00%, on 351 volume with 2 trades. The average volume for the last 3 months is 334 and the stock's 52-week low/high is $0.222/$1.45.
Rainforest Resources, Inc. (RRIF)
High Rising Stocks, OTC Markets, Stockhouse, InvestorsHub, 4-Traders, TradingView, Simply Wall St, Wallet Investor, Barchart, MarketWatch, YCharts, Penny Stock Hub, Wallmine, Stockopedia, Stockflare, Investing News Alerts, and Wall Street Pennies reported earlier on Rainforest Resources, Inc. (RRIF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Rainforest Resources, Inc.’s mission is to protect the ecosystems of the rainforest to reduce the impact of global warming. Rainforest Resources operates in the forestry sector. As part of its dedication to prevent global warming, the Company is making the best of efforts to preserve the rainforest, the initial phase being the “Huamboya Forest” Morona Santiago – Ecuador. At Huamboya, millenary trees and endemic species of the Amazon, terrestrial, aquatic, as well as aerial are found. Rainforest Resources has its U.S. office in Anna Maria, Florida.
The Company, in its dedication to ease global warming, commits all its efforts and economic support for the conservation of the humid forest. Furthermore, it produces carbon credit certificates and develops and exports natural spring water.
Rainforest Resources’ positions are in tropical rain forests, land for reforestation, and above all clean air. The Company’s vision is to sustain forestry and to live in harmony with forestry in itself.
Rainforest Resources is interested in conserving the Huamboya ecosystem. Huamboya presents a Humid Tropical Megathermal climate. The forest is covered by native forest without human intervention.
The Huamboya forest has about 586 endemic plant species of which 45 percent are orchids. The forest has a rich diversity of animal life. This includes 343 species of birds, 100 species of mammals, and more than 500 species of vertebrates.
Recently, Rainforest Resources announced, by way of its subsidiary Rain Forest Enterprises SA, that it purchased from Latitude Aerospace Solutions (LAS) a state of the art Drone model VTOL. When fitted with remote sensors, the Drone can detect the effect of greenhouse gases in a given area and provide data on CO2 and Oxygen levels. This is important information used in the computation for the issuance of Verified Emission Reductions (VERs)/Certified Emission Reductions (CERs).
The initial use of the Drone will be in the evaluation of Rainforest Resources’ rain forest properties in Ecuador to produce Verified Carbon Credit Certificates. Subsequently, it is the Company’s intention to provide the Drone services to other entities involved in the ecological preservation of the rainforests in Ecuador on a cost-plus basis. This will provide additional income to Rainforest Resources.
Rainforest Resources, Inc. (RRIF), closed Monday's trading session at $5.85, up 25.54%, on 2,133 volume with 9 trades. The average volume for the last 3 months is 512 and the stock's 52-week low/high is $3.50/$9.20.
AEON Global Health Corp. (AGHC)
Amigo Bulls, Stock Target Advisor, Stockopedia, Investors Hangout, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockflare, and Dividend Investor reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company provides diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. AEON formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. OTCQB-listed, AEON Global Health has its corporate office in Gainesville, Georgia.
The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results. AEON’s chief business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.
AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. It provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses. These include CHF, COPD and Diabetes.
Concerning Toxicology Testing, AEON Global Health provides accurate and fast quantitative testing of drug metabolite levels in urine and oral ﬂuids. The Company’s testing covers more than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.
AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.
In May 2018, AEON Global Health announced it earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization’s commitment to providing safe and effective patient care.
AEON Global Health underwent a thorough onsite survey earlier in 2018. During the review, a Joint Commission expert surveyor evaluated compliance with laboratory standards related to a number of areas. This included document and process control, healthcare-associated conditions, risk reduction, as well as staff qualifications and competency. Additionally, the surveyor conducted onsite observations and interviews.
AEON Global Health Corp. (AGHC), closed Monday's trading session at $0.2149, up 0.42%, on 13,947 volume with 7 trades. The average volume for the last 3 months is 1,914 and the stock's 52-week low/high is $0.156/$1.09.
The QualityStocks Company Corner
- Youngevity International, Inc. (NASDAQ: YGYI)
- Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
- City View Green Holdings Inc. (CSE: CVGR)
- Endonovo Therapeutics Inc. (ENDV)
- Golden Developing Solutions, Inc. (DVLP)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Sharing Services Global Corporation (SHRG)
- Marijuana Company of America Inc. (MCOA)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Youngevity International, Inc. (NASDAQ: YGYI)
Khrysos Industries, Inc. a wholly owned subsidiary of Youngevity International, Inc. (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise announced today that it has entered into a 5 year Supply Contract with Magu Maiden Farms, LLC to provide extraction services and end-to-end processing to produce isolate, water soluble isolate, distillate, and water-soluble distillate hemp derived products.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed Monday's trading session at $5.52, up 2.98%, on 98,410 volume with 749 trades. The average volume for the last 3 months is 96,114 and the stock's 52-week low/high is $3.167/$16.25.
- Khrysos Industries, Inc., a wholly owned subsidiary of Youngevity International, Inc. (NASDAQ: YGYI), Enters Into a 5-Year Supply Contract to purchase Hemp Plant Biomass for Extraction, Processing and Production of Hemp-Derived Products
- Youngevity International, Inc (Nasdaq:YGYI) set to join Russell 3000 Index
- 420 with CNW – Arizona Medical Cannabis Dispensaries Celebrate Supreme Court Decision on Concentrates as Sales Soar
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce its first commercial sale of cannabis flower in Canada. “Recognizing our first commercial sale to another, well recognized, licensed producer is a milestone that we are very proud of. This shipment marks the beginning of Sproutly’s revenue stream and demonstrates our teams ability to, once again, deliver on our strategy.” - said Keith Dolo, Chief Executive Officer, Sproutly Canada.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed Monday's trading session at $0.524, up 10.29%, on 355,958 volume with 143 trades. The average volume for the last 3 months is 818,172 and the stock's 52-week low/high is $0.189/$1.875.
- Sproutly Announces First Commercial Sale of Cannabis Flower
- Sproutly Canada Inc.’s (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Proprietary Water-Soluble CBD Formula to be Delivered in Consumable Brands
- NetworkNewsBreaks – Sproutly Canada Inc.’s (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Premium Cannabis Brand Aims to Deliver Superior Experience
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “Company”) is pleased to announce that it has received and fulfilled an opening purchase order from Dillard’s department stores that will place Wildflower wellness products in Dillard’s stores across the US. Wildflower’s premium hemp CBD infused products can now be seen throughout 292 Dillard’s locations across the U.S. and the company’s retail presence throughout the country continues to expand. Also today, CannabisNewsWire released a report highlighting the company which examines how skepticism has been squashed and all apprehension eliminated in the cannabis sector. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Monday's trading session at $0.4849, up 7.089%, on 33,442 volume with 14 trades. The average volume for the last 3 months is 23,628 and the stock's 52-week low/high is $0.009/$1.129.
- Wildflower Expands Nationwide Retail Presence with Dillard’s Department Stores
- Searching for the Next Super Nova
- NetworkNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) CBD Line Featured in New York City Salon
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
Choom (CSE: CHOO; OTCQB: CHOOF), is pleased to announce that Choom Niagara, the first legal, adult use cannabis store to operate in Niagara Falls, ON has produced over $49,000 in sales on its opening day. "We are really happy with the turnout we had for Choom Niagara's opening day." states Chris Bogart, President and CEO of Choom "We've had a lot of support from the local community, and we're excited to bring Choom to Niagara Falls. The feedback from our customers has been fantastic, and that is a testament to our dedicated staff and in-store experience. Doing over $49,000 in sales on the first day of operation is a great milestone for us and our team who have worked so hard to get where we are today."
Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.
Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.
True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.
Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.
A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.
While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.
Choom Holdings Inc. (CHOOF), closed Monday's trading session at $0.3665, up 1.8056%, on 385,954 volume with 230 trades. The average volume for the last 3 months is 402,070 and the stock's 52-week low/high is $0.2849/$1.129.
- Choom Surpasses $49,000 in Opening Day Sales at the Niagara Flagship Cannabis Store
- Choom to Open Niagara Falls' First Cannabis Store
- Consumer Cannabis Spending Should Spur Increase In Dispensaries And Cultivation Operations In 2019
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings (CSE: CVGR), formerly Icon Exploration Inc., is a vertically integrated, seed-to-sale cannabis company that intends to grow high-quality cannabis and produce extracts. Presently, CVGR is making progress to wrap up its Brantford, Ontario, facility in the coming months and anticipates receiving a license from Heath Canada permitting it to turn building into an operational cannabis grow-and-extraction facility. To view the full press release, visit: http://nnw.fm/yDQ22.
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Monday's trading session at $0.1050, up 5.00%, on 48,892 volume with 9 trades. The average volume for the last 3 months is 209,133 and the stock's 52-week low/high is $0.0949/$0.465.
- NetworkNewsBreaks – City View Green Holdings Inc. (CSE: CVGR) Anticipates Completion of Brantford Facility Build-Out
- City View Holdings Inc. and Budd Hutt Inc. Announce Agreement to Acquire 8 Retail Cannabis Store Locations in Alberta: Receives Strategic Investment from Quinsam Capital for $1.1M
- City View Green Holdings Inc. (CSE: CVGR) Working to Be Premier Purveyor of Medicinal, Recreational Cannabis Products
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics Inc. (ENDV) was featured in a report today from NetworkNewsWire. The global wearable medical devices market is anticipated to grow to $66.8 billion by 2026, a Grandview Research report published in April 2019 suggests (http://nnw.fm/Z72qG). The market is forecast to expand at a CAGR of 26.1 percent over the period, with several factors contributing to the growth.
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Endonovo Therapeutics Inc. (ENDV), closed Monday's trading session at $0.0125, up 8.6957%, on 3,862,728 volume with 89 trades. The average volume for the last 3 months is 3,228,412 and the stock's 52-week low/high is $0.0089/$0.0661.
- Endonovo Therapeutics Inc. (ENDV) Positioned to Benefit as Wearable Medical Devices Market Projected to Reach $66.8 Billion by 2026
- Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
- NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Secures Agreement to Distribute SofPulse to Veteran Health Care Facilities
Golden Developing Solutions, Inc. (DVLP)
Golden Developing Solutions, Inc. (OTCMKTS: DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is excited to announce updated financial data as the Company’s growth rate continues to accelerate following key strategic moves, including expanded production capacity and the acquisition of Infusionz, LLC (“CBD Infusionz”). In combined terms, the Company booked over $629K in monthly sales in May alone, with an annualized sequential monthly sales growth rate of nearly 160%. Also today, the company was highlighted in a publication examining how DVLP has signed a preliminary partnership agreement with DNA Brands Inc. to reformulate its two-time award winning energy drink line with CBD and natural sweeteners. The agreement will allow DVLP to work with the DNA scientific team to reformulate, market and distribute the two-time award winning line of energy drinks.
Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.
Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.
DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.
DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.
WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.
“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”
The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.
“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”
Golden Developing Solutions, Inc. (DVLP), closed Monday's trading session at $0.016, even for the day, on 6,655,001 volume with 230 trades. The average volume for the last 3 months is 3,691,340 and the stock's 52-week low/high is $0.01219/$0.14.
- DVLP Updates Financial Performance, Signals 160% Overall Growth Across Multiple Segments
- DNA Signs Preliminary Agreement to Enter CBD Marketplace with Golden Developing Solutions (DVLP)
- DVLP Announces Move-In Date for New Denver CBD Production Facility
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), manufacturer and marketer of cannabis food products, has purchased an option to buy California-based cannabis oil manufacturer Emerald Bay Wellness LLC and the business assets of Emerald Bay Extracts. The option specifies cash and stock consideration for PLUS to acquire one of its largest cannabis oil suppliers and a supply partner for more than a year (http://nnw.fm/atAg9).
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Monday's trading session at $3.00, off by 6.4925%, on 48,173 volume with 107 trades. The average volume for the last 3 months is 76,035 and the stock's 52-week low/high is $2.8099/$6.008.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Offers Secured Loan for Option to Buy Cannabis Oil Manufacturer
- Booming Supply and Demand Conditions Fueling Growing Number of Acquisitions in Cannabis Markets
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Q1 Results, Begins Trading on OTCQX Best Market
Sharing Services Global Corporation (SHRG)
Sharing Services Global Corporation (OTCQB: SHRG), a diversified holding company that owns, operates or controls an interest in a variety of companies specializing in the direct selling industry, continues to weather the storms of shifting market trends by combining enthusiastic independent sales representatives with its creative brand strategy.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.163, off by 9.44%, on 930 volume with 1 trade. The average volume for the last 3 months is 22,134 and the stock's 52-week low/high is $0.14245/$0.3944.
- Sharing Services Global Corporation (SHRG) Empowers Elepreneurs to Achieve Wellness in Both Mind and Body
- Sharing Services Global Corporation (SHRG) Names Two Elepreneur Execs to Board, Advances Nasdaq Uplisting Process
- NetworkNewsBreaks – Sharing Services Inc. (SHRG) Continues Growth Utilizing Blue Ocean Strategy
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (MCOA) was featured today in the 420 with CNW by CannabisNewsWire. Activists in Mississippi have revealed that they are about to reach the required number of voter signatures in order to see an initiative about medical marijuana included on the ballot in 2020. Once the organizers submit that list of signatures, the Secretary of State will go through it and certify that each of the signatures belongs to a valid voter in the state. The organizers have emphasized that they will not stop once they reach the minimum number of signatures required. Instead, they will keep gathering more until the submission deadline in September is reached.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.011492, off by 1.7778%, on 7,825,424 volume with 169 trades. The average volume for the last 3 months is 10,524,019 and the stock's 52-week low/high is $0.01025/$0.0489.
- 420 with CNW – Mississippi Medical Cannabis Ballot Measure Close to Attaining Signature Target
- CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
- Why the U.S. Farm Bill Changed the Balance Of Power In Global Hemp Market
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Monday's trading session at $0.23, up 2.8085%, on 66,020 volume with 13 trades. The average volume for the last 3 months is 234,068 and the stock's 52-week low/high is $0.208/$1.429.
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Redesigning Oil and Gas Industry with Cost-Efficient, Environmentally Friendly Technology
- NetworkNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Generates Funds to Continue Development of Extraction Technology
- Petroteq Energy Inc.'s (TSX.V: PQE) (OTCQX: PQEFF) Patented Oil Extraction Technology Releases Hidden Energy Buried in Oil Sands
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.
Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.
Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.
Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.
In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.
Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.
Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:
- FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
- Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
- Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.
Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.
Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.
The Flowr Corporation (TSX.V: FLWR), closed Monday's trading session at $5.37, up 5.7087%, on 96,786 volume with 251 trades. The average volume for the last 3 months is 81,068 and the stock's 52-week low/high is $2.18/$6.30.
- NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) CEO to Participate in Panel Discussion at Piper Jaffray’s 39th Annual Consumer Marketplace Conference
- Flowr to Participate on Cannabis Panel at the Piper Jaffray Consumer Marketplace Conference on June 6, 2019
- NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Receives Approval for NASDAQ Listing
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.
The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.
“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”
Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.
LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.
Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.
The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.
Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.
World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.
Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.
Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.
The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.
Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.
Standard Lithium Ltd. (OTC: STLHF), closed Monday's trading session at $0.5714, up 1.474%, on 11,550 volume with 13 trades. The average volume for the last 3 months is 30,377 and the stock's 52-week low/high is $0.4839/$1.3874.
- Standard Lithium Provides Progress Update on its Industrial-Scale Lithium Extraction Demonstration Plant
- NetworkNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) CEO to Present at LD Micro Invitational Conference
- Standard Lithium Announces Receipt of Additional $426,000 to Proceeds of $1.00 Offering
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.
Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.
The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.
Foresight has developed three main products:
- QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
- Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
- Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.
In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.
Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.
Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.
Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.
Foresight Autonomous Holdings Ltd. (FRSX), closed Monday's trading session at $0.8499, up 4.9259%, on 19,435 volume with 39 trades. The average volume for the last 3 months is 46,687 and the stock's 52-week low/high is $0.697/$4.429.
- Foresight Opens Demonstration Center to Investors
- NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Launches QuadSight Demonstration Center
- Foresight Successfully Completes Technological Demonstrations for Leading Vehicle Manufacturers in France
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Renews Access Agreements for Port and Power & Provides Project Update
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) in Final Negotiations to Significantly Expand Cannabis Cultivation and Retail Operations
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Grant of Incentive Stock Options
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Resignation of Non-Executive Chairman
- ChineseInvestors.com (CIIX) Projects Continued Revenue Growth for FY2020
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Open Niagara Falls' First Cannabis Store
- City View Green Holdings Inc. (CSE: CVGR) and Budd Hutt Inc. Announce Agreement to Acquire 8 Retail Cannabis Store
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Earth Science Tech, Inc. (ETST) 420 with CNW – Church of England Starts Investing in Marijuana
- Endonovo Therapeutics (OTCQB: ENDV) Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Opens Demonstration Center to Investors
- Genprex Inc. (NASDAQ: GNPX) Advances Toward Lead Drug
- Geyser Brands Inc. (TSX.V: GYSR) Aims to Become Leading Provider of Health-Focused CBD, Hemp Products
- Golden Developing Solutions, Inc. (DVLP) Announces Move-In Date for New Denver CBD Production Facility
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Consumer Cannabis Spending Should Spur Increase In Dispensaries And Cultivation Operations In 2019
- Green Hygienics Holdings Inc. (GRYN) Registered to Cultivate Industrial Hemp in San Diego County, California
- QualityStocksNewsBreaks – Hemptown USA Positioned as Leading Producer of CBG — Potential Next Big Thing
- INmune Bio, Inc. (NASDAQ: INMB) Featured in Exclusive NetworkNewsWire Broadcast
- IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF) Completes Acquisition of Vegas Valley Growers North
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) DehydraTECH: The Cynosure of Efficient CBD Delivery -- CFN Media
- Marijuana Company of America Inc. (MCOA) CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
- MustGrow Biologics Corp. is “One to Watch”
- Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Enters Definitive Agreement to Acquire Desert Hot Springs, California Dispensary
- Net Element, Inc. (NASDAQ: NETE) Launches Artificial Intelligence-Based Underwriting Solution
- Nightfood, Inc. (OTCQB: NGTF) National Supermarket Rollout Supported by Moms Meet, Introducing Nightfood to Almost Two Million Moms Across the Country
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Featured in NetworkNewsAudio Broadcast on Growth of Indonesian Nickel Market
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Revolutionizing Oil, Gas Industry with Environmentally Friendly Production Platform
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Booming Supply and Demand Conditions Fueling Growing Number of Acquisitions in Cannabis Markets
- Pressure BioSciences Inc. (PBIO) PCT Platform Prominently Featured in Record Number of Presentations at Major International Science Conference
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Assay Results Suggest Further Tonnage at Irgon Property
- Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) Notes from the Floor: Lift Cannabis Business Conference Toronto
- Sharing Services Global Corporation (SHRG) Names Two Elepreneur Execs to Board, Advances Nasdaq Uplisting Process
- SinglePoint, Inc. (SING) Focused on Acquiring Companies that Benefit from Technology Integration, Growth Capital Injection
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Advancing Unique Commercial Cellular Device for Public Safety and Commercial Fleet Vehicles
- Spectrum Global Solutions, Inc. (SGSI) Bundled Services Strategy Provides Edge in Telecommunications Growth Market
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Proprietary Water-Soluble CBD Formula to be Delivered in Consumable Brands
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Provides Progress Update on its Industrial-Scale Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Featured in CannabisNewsAudio Broadcast on Importance of CBD Extraction Providers
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Positioned to Deliver Innovative Products Worldwide
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) CEO to Participate in Panel Discussion at Piper Jaffray’s 39th Annual Consumer Marketplace Conference
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces 2019 AGM Voting Results, Enters Multi-Year Agreement with Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT)
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Missouri Puts Final Touches to Medical Marijuana Rules
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Lyfted Acquisition Puts ‘Finger in Many Pies’
- Trxade Group Inc. (TRXD) Subsidiary Secures LegitScript Certification
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Subsidiary’s Project Moves to 2nd Phase of Health Canada Review, Approval
- VPR Brands, LP (VPRB) Fostering Steady Year-over-Year Growth
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) CBD Line Featured in New York City Salon
- Youngevity International, Inc. (NASDAQ: YGYI) set to join Russell 3000 Index
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.